KELSEY REID: Open Payments
NPI 1942764840 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$383 in 26 payments from 7 companies in 2025. Trend: 2023 $176 · 2024 $365 · 2025 $383
Food & beverage: $383
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $166 |
| Novo Nordisk Inc | 4 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Viatris Specialty LLC | 2 | $36 |
| Dexcom, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Amgen Inc. | 1 | $14 |
Products named: VRAYLAR, AIRSUPRA, Wegovy, YUPELRI, QULIPTA, Dexcom G6 Transmitter, CAPVAXIVE, Rybelsus.
Industry payments across MO — which companies pay providers there.
